Abstract PD14-09: Nci 10013 - A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel, with or without atezolizumab in triple negative breast cancer (TNBC)
Year: 2021
Type: conference-abstract
Source: Cancer Research
Institutions: Washington University in St. Louis, Mayo Clinic in Arizona, The Ohio State University, University of California, Davis, University of Pittsburgh, University of North Carolina at Chapel Hill, Johns Hopkins University, University College Cork, Duke University, Mayo Clinic in Florida, National Cancer Institute
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3131622108